Kearney Regional Medical Center is the first hospital in Nebraska to utilize Telecytology in partnership with the University of Nebraska Medical Center in Omaha (UNMC). Telecytology is the interpretation of cell samples and structure remotely using digital images. Common uses for this technology include biopsying the thyroid gland for cancer.
Patient specimens are collected using a small, hollow needle in the patient’s thyroid gland using Rapid Onsite Evaluation (ROSE).
The on-site histologist at KRMC and the UNMC doctor connect via Skype for Business. Once it is determined the sample is adequate for interpretation, it will be curried to Omaha to be fully-processed and read for diagnosis. The patient will then come back to KRMC in about five days to review their results in-person with their physician.
As feedback is immediate, inadequate biopsies are reduced and repeat biopsies are largely avoided.
The service is also available to clinic patients of Platte Valley Medical Group, a wholly-owned subsidiary of KRMC.
Dr. Ana Yuil-Valdes, a Pathologist at the University of Nebraska Medical Center, shared about this partnership during the C.A.R.E. (Celebration and Recognition of Excellence) Forum on June 28, 2019.